JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.12 Cr | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.12 Cr |
| Mar2024 | ₹2.98 Cr |
| Mar2023 | ₹3.24 Cr |
| Mar2022 | ₹3.92 Cr |
| Mar2021 | ₹3.99 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.12 Cr | 38.12 | |
| Mar2024 | ₹2.98 Cr | -7.82 | |
| Mar2023 | ₹3.24 Cr | -17.36 | |
| Mar2022 | ₹3.92 Cr | -1.81 | |
| Mar2021 | ₹3.99 Cr | - | |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹518.4 Cr | 4.9% | 2.2% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,785.0 Cr | 0.4% | -4.6% | 6.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,242.0 Cr | 0.7% | -1.1% | 2.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,058.0 Cr | 2.9% | -1.2% | 42.7% | Stock Analytics | |
| CIPLA | ₹111,180.0 Cr | -1.5% | 5.5% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,149.0 Cr | 0.4% | -0.6% | 1.3% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 4.9% |
2.2% |
-10.2% |
| SENSEX | -0.5% |
-4.3% |
-8.4% |
You may also like the below Video Courses